Novo Holdings A/S Top Holdings and 13F Report (2025) About Novo Holdings A/SInvestment ActivityNovo Holdings A/S has $1.23 billion in total holdings as of June 30, 2025.Novo Holdings A/S owns shares of 22 different stocks, but just 12 companies or ETFs make up 80% of its holdings.Approximately 3.86% of the portfolio was purchased this quarter.About 12.42% of the portfolio was sold this quarter.This quarter, Novo Holdings A/S has purchased 24 new stocks and bought additional shares in 3 stocks.Novo Holdings A/S sold shares of 7 stocks and completely divested from 3 stocks this quarter.Largest Holdings Edgewise Therapeutics $168,525,000Brookfield $141,493,035ASML $125,407,525Mirum Pharmaceuticals $122,403,500MAPLIGHT THERAPEUTICS INC $74,949,025 Largest New Holdings this Quarter 98420N105 - Xenon Pharmaceuticals $28,228,220 Holding Largest Purchases this Quarter Xenon Pharmaceuticals 485,438 shares (about $28.23M)Salesforce 63,000 shares (about $11.76M)Mirum Pharmaceuticals 60,972 shares (about $5.63M)BRIDGEBIO ONCOLOGY THERAPEUT 224,606 shares (about $2.01M) Largest Sales this Quarter ASML 19,000 shares (about $25.10M)APOGEE THERAPEUTICS INC 120,000 shares (about $10.10M)Enliven Therapeutics 200,000 shares (about $7.84M)Valneva 1,247,579 shares (about $7.80M)Viridian Therapeutics 380,000 shares (about $7.43M) Sector Allocation Over TimeMap of 500 Largest Holdings ofNovo Holdings A/S Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorEWTXEdgewise Therapeutics$168,525,0000.0%5,350,00013.7%MedicalBNBrookfield$141,493,0350.0%3,496,24511.5%FinanceASMLASML$125,407,525$25,095,770 â–¼-16.7%94,94610.2%Computer and TechnologyMIRMMirum Pharmaceuticals$122,403,500$5,632,593 â–²4.8%1,325,0009.9%MedicalMAPLIGHT THERAPEUTICS INC$74,949,0250.0%3,686,6226.1%COMCRMSalesforce$73,396,217$11,760,210 â–²19.1%393,1875.9%Computer and TechnologyCRNXCrinetics Pharmaceuticals$56,296,000$2,724,000 â–¼-4.6%1,550,0004.6%MedicalELVNEnliven Therapeutics$50,176,000$7,840,000 â–¼-13.5%1,280,0004.1%MedicalPCVXVaxcyte$49,974,600$3,263,458 â–¼-6.1%860,0004.0%MedicalPHVSPharvaris$49,437,5000.0%1,750,0004.0%MedicalARRIVENT BIOPHARMA INC$44,805,2160.0%1,942,1423.6%COMVRDNViridian Therapeutics$39,120,000$7,432,800 â–¼-16.0%2,000,0003.2%MedicalCLDXCelldex Therapeutics$38,064,0000.0%1,200,0003.1%MedicalAPOGEE THERAPEUTICS INC$37,876,500$10,100,400 â–¼-21.1%450,0003.1%COMBMRNBioMarin Pharmaceutical$37,283,4000.0%660,0003.0%MedicalFDMT4D Molecular Therapeutics$33,988,3610.0%3,650,7372.8%MedicalBABAAlibaba Group$32,284,2450.0%257,3272.6%Retail/WholesaleXENEXenon Pharmaceuticals$28,228,220$28,228,220 â–²New Holding485,4382.3%MedicalBRIDGEBIO ONCOLOGY THERAPEUT$19,564,011$2,010,224 â–²11.5%2,185,9231.6%COM NEWVALNValneva$6,608,881$7,797,368 â–¼-54.1%1,057,4210.5%MedicalLANZATECH GLOBAL INC$2,531,9490.0%158,1480.2%COM NEWMQMarqeta$1,801,5570.0%441,5580.1%Business ServicesZENAS BIOPHARMA INC$0$52,649,500 â–¼-100.0%00.0%COMINSMInsmed$0$34,808,000 â–¼-100.0%00.0%MedicalIOBTIO Biotech$0$1,529,833 â–¼-100.0%00.0%MedicalShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
